Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756804 · ClinicalTrials.gov registry record · Phase 3
Perioperative Patient Skin Antiseptic Preparation Evaluation
A Phase 3 study, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 51
- Enrollment target
NCT04756804 is a Phase 3 study that has completed, run by Zurex Pharma. The registered enrollment target is 51 participants.
The verdict
NCT04756804, a Phase 3 study, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 51 participants
- Enrollment target
Study Summary
This study will evaluate a new topical skin antiseptic perioperative preparation and the standard of care to determine efficacy on the rates of surgical site infections of surgical patients. Safety will also be assessed.
Interventions
- DRUG 70% v/v Isopropyl Alcohol Surgical Solution
- DRUG 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2022-09-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04756804
The ClinicalTrials.gov registry entry for NCT04756804 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zurex Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 70% v/v Isopropyl Alcohol Surgical Solution is the first listed.
NCT04756804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04756804 about?
NCT04756804 is a clinical study titled "Perioperative Patient Skin Antiseptic Preparation Evaluation". This study will evaluate a new topical skin antiseptic perioperative preparation and the standard of care to determine efficacy on the rates of surgical site infections of surgical patients. Safety will also be assessed.
What is the current status of trial NCT04756804?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 51 participants. The study started on 2021-06-21. Estimated completion is 2022-09-29.
What interventions are being tested in trial NCT04756804?
The interventions under investigation include: 70% v/v Isopropyl Alcohol Surgical Solution (DRUG), 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol (DRUG).
Who is sponsoring clinical trial NCT04756804?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.